Update
PHI’s Oregon Public Health Institute and Bridge Center Receive Inaugural NNPHI Award
-
Focus Areas
Alcohol, Tobacco, Drugs & Mental Health -
Issues
Rural Health -
Expertise
Quality Improvement -
Programs
Bridge -
Strategic Initiatives
Opioids
The Oregon Public Health Institute (OPHI) and the Bridge Center (Bridge), programs of the Public Health Institute (PHI), received the National Network of Public Health Institutes (NNPHI) inaugural 2026 Outstanding Collaboration Award for their partnership in launching an emergency medical services (EMS) buprenorphine roadmap. Co-developed with the Oregon Health Authority, the project’s funding partner, the roadmap provides evidence-based guidance, operational steps and advocacy strategies to support EMS-delivered buprenorphine in Oregon. Bridge contributed national expertise from prior pilots, while OPHI brought connections to local partners, navigation of Oregon’s behavioral health and public health systems and strategic guidance that enabled rapid, effective implementation. Together, they partnered with EMS agencies, emergency clinicians and local champions to deliver pilot trainings, workgroups and convenings statewide.
Under the EMS Bridge model, paramedics administer buprenorphine in the ambulance and use motivational interviewing to connect patients to emergency departments that treat opioid use disorder. For patients with opioid use disorder, buprenorphine has shown to increase odds of continued treatment, and decrease mortality by 70% following non-fatal overdoses. The pilot reached 186 participants across seven urban and rural counties through seven trainings and convenings, leading to immediate practice changes, stronger EMS–ED coordination and improved continuity of care.
The NNPHI Awards Program recognizes outstanding individuals and organizations that make exemplary contributions to improving the public’s health and embody NNPHI’s mission and values.
See Also: PHI's Bridge Center Highlighted in California Health Report
Bridge trains EMS units in rural communities to administer buprenorphine in the ambulance, helping to expand access to critical lifesaving care. Studies indicate that treatment with buprenorphine significantly reduces mortality by 70%.
Originally published by NNPHI
More Updates
Work With Us
You change the world. We do the rest. Explore fiscal sponsorship at PHI.
Support Us
Together, we can accelerate our response to public health’s most critical issues.
Find Employment
Begin your career at the Public Health Institute.